Efficacy of First-Line Nivolumab Plus Ipilimumab in Unresectable Pleural Mesothelioma: A Multicenter Real-World Study (ImmunoMeso LATAM) von Enrico, Diego, Gomez, Juan Elias, Aguirre, Danilo, Tissera, Natalia Soledad, Tsou, Florencia, Pupareli, Carmen, Tanco, Delfina Peralta, Waisberg, Federico, Rodríguez, Andrés, Rizzo, Manglio, Minatta, Nicolás, Rafael, Picon, Basbus, Luis, Lupinacci, Lorena, Kaen, Diego, Ramos, Mauro, Bluthgen, Virginia, Castagneris, Nicolas, Coppola, María Pía, Scocimarro, Alejandra, Guerra, María Florencia, Perfetti, Aldo, Levit, Patricio, Galvez-Nino, Marco, Mas, Luis, Rojas, Leonardo, Zuluaga, Jairo, Chacón, Matías, Corrales, Luis, Samtani, Suraj, Arrieta, Oscar, Cardona, Andrés, Remon, Jordi, Martín, Claudio

Volltext